Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.55 USD | -1.39% | +13.42% | +184.00% |
08/05 | Lexaria Bioscience Corp. Begins Dosing of Its Second Glp-1 Human Pilot Study | CI |
16/04 | Lexaria Obtains Ethics Review Board Approval to Start New GLP-1 Study | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+184.00% | 4.57Cr | |
+30.38% | 68TCr | |
+29.62% | 57TCr | |
-4.36% | 36TCr | |
+19.30% | 33TCr | |
+3.73% | 28TCr | |
+16.36% | 24TCr | |
+9.47% | 21TCr | |
-7.16% | 20TCr | |
+7.68% | 17TCr |
- Stock Market
- Equities
- LEXX Stock
- News Lexaria Bioscience Corp.
- Lexaria Bioscience to Start Diabetes, Weight Loss Animal Study; Shares Rise